abstract |
The present invention relates to a novel combination tablet formulation containing four active components such as paracetamol 35 to 45% w / w total tablet weight, propyphenazone 25-37% w / w total tablet weight, codeine phosphate 1.1 to 1 , 9% w / w total tablet weight and caffeine 5-9% w / w total tablet weight as well as the procedures for obtaining it. |